IBEC and Vitala, a spin-off founded by IBEC researchers, are set to participate in three public-private partnership projects, with a combined investment nearing €4 million. These initiatives, backed by the Spanish Ministry of Science and Innovation and the State Research Agency, aim to advance remote health monitoring, create an oral drug for Inflammatory Bowel Disease, and enhance 13C magnetic resonance imaging for therapeutic research. Leveraging cutting-edge technological approaches, these endeavors aspire to make a positive impact on the fields of medicine and biomedical research.
A research team led by IBEC and Hospital del Mar has conducted a study to analyze cough sounds recorded by smartphones in patients with COVID-19. The results reveal cough characteristics that could offer a quick, easy, and cost-effective method for identifying the severity of the disease in patients, whether at home or in any healthcare setting. This work also paves the way for utilizing this model in the ongoing monitoring of patients with persistent COVID-19 and other respiratory pathologies.